)
Cytosorbents (CTSO) investor relations material
Cytosorbents Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting scheduled for August 13, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and annual report for the year ended December 31, 2025, prior to voting.
Voting matters and shareholder proposals
Election of five director nominees: Phillip P. Chan, Michael G. Bator, Edward R. Jones, Alan D. Sobel, and Jiny Kim.
Advisory vote on executive compensation for named executive officers.
Ratification of WithumSmith + Brown, PC as independent auditors for fiscal year ending December 31, 2026.
Approval of a reverse stock split at a ratio between 1-for-5 and 1-for-20, at the Board's discretion, within one year of approval.
Approval to adjourn the meeting if necessary to solicit additional votes.
Provision to conduct other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and all proposals.
- Shareholders will vote on director elections, executive pay, auditor ratification, and a reverse stock split.CTSO
Proxy filing25 Jun 2026 - Strong sales, high margins, and advancing FDA approvals position for growth in critical care.CTSO
Life Sciences Virtual Investor Forum24 Jun 2026 - Key votes include director elections, say-on-pay, auditor ratification, and a reverse stock split.CTSO
Proxy filing11 Jun 2026 - Q1 2026 revenue up 2% to $8.9M; cost cuts, regulatory progress, and FX losses shape outlook.CTSO
Q1 202619 May 2026 - Revenue up 4% to $37.1M, margins improved, and cash flow breakeven targeted for H2 2026.CTSO
Q4 20251 Apr 2026 - Q2 2024: revenue up 5%, operating loss down 48%, cash runway extended, funding risks persist.CTSO
Q2 20241 Feb 2026 - DrugSorb-ATR nears FDA submission, aiming to transform bleeding risk management in cardiac surgery.CTSO
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026 - Product sales up 11%, net loss narrows, and DrugSorb-ATR regulatory reviews advance.CTSO
Q3 202415 Jan 2026 - Record 2024 sales, margin gains, and regulatory progress set up a pivotal 2025.CTSO
Q4 202425 Dec 2025
Next Cytosorbents earnings date
Next Cytosorbents earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)